Skip to content

Effect of deep neuromuscular blockade and low-pressure pneumoperitoneum combined with lung-protective ventilation strategy on quality of postoperative recovery in obese patients undergoing gynecological laparoscopic surgery

Effect of deep neuromuscular blockade and low-pressure pneumoperitoneum combined with lung-protective ventilation strategy on quality of postoperative recovery in obese patients undergoing gynecological laparoscopic surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088637
Enrollment
Unknown
Registered
2024-08-22
Start date
2023-05-17
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological diseases in obese patient

Interventions

Group N:deep neuromuscular blockade and low-pressure pneumoperitoneum combined with lung-protective ventilation strategy was used during operation
Group C:moderate neuromuscular blockade and high-pressure pneumoperitoneum combined with conventional intermittent positive pressure ventilation mode

Sponsors

Affiliated Boai Hospital of Zhongshan, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
24 Years to 64 Years

Inclusion criteria

Inclusion criteria: ?Patients who met the criteria for gynecological elective laparoscopic surgery ?Patients aged 24-64 years and able to tolerate surgery and anesthesia ?ASA(American society of anesthesiologists)I~II ?BMI=30kg/m2 ?The functions of heart, lung, liver, brain and kidney are normal; No previous history of brain injury, brain surgery or epilepsy ?Laparoscopic surgery was performed under general anesthesia ?volunteered to participate in this study and signed informed consent forms before operation

Exclusion criteria

Exclusion criteria: ?Patients with neuromuscular functional defect such as myasthenia gravis and those who take drugs affecting neuromuscular conduction function for a long time ?Patients with a history of cardiac insufficiency or heart failure who cannot tolerate neostigmine and atropine ?Hepatic and renal insufficiency ?Combined with pulmonary infection and tuberculosis;Suffer from chronic lung obstruction,bronchial asthma and other diseases ?Patients who cannot accept the monitoring of neuromuscular block depth

Design outcomes

Primary

MeasureTime frame
The incidence and severity of pulmonary complications (PPCs) on the 1st, 3rd, 7th, and 30th day after the operation and cumulative incidence within 30 days after the operation in both groups;ambulation time ;discharge time;

Secondary

MeasureTime frame
Abdominal pain score on the 1st and 2nd day after the operation;Operator's satisfaction with exposure of operation field;Mean arterial pressure (MAP), Pulse rate (HR) and pressure in airway (Paw) were recorded before pneumoperitoneum (T0) and 1 hour after pneumoperitoneum (T1).;arterial blood gas analysis 1 hour after pneumoperitoneum (T1).;The recovery time of the train of four ratio to 0.7, 0.9;recovery time;

Countries

China

Contacts

Public ContactLuo Guozhan

Department of Anesthesiology.Affiliated Boai Hospital of Zhongshan, Southern Medical University

649074580@qq.com+86 139 2537 2507

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026